To include your compound in the COVID-19 Resource Center, submit it here.

Corbus raises $32.6M in follow-on

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) raised $32.6 million through the sale

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE